What does CUSIP 76155X100 represent in this 13F holders report?

CUSIP 76155X100 is the security identifier for RVMD - Revolution Medicines, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held RVMD - Revolution Medicines, Inc. - Common Stock in Q2 2022?

125 institutional investors reported RVMD - Revolution Medicines, Inc. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Revolution Medicines, Inc. - Common Stock (RVMD)

CUSIP: 76155X100

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 192,966,469
Total 13F shares: 76,461,750
Share change: +2,578,059
Total reported value: $1,490,187,152
Put/Call ratio: 0%
Price per share: $19.49
Number of holders: 125
Value change: +$40,971,035
Number of buys: 60
Number of sells: 47

Quarterly Holders Quick Answers

What is CUSIP 76155X100?
CUSIP 76155X100 identifies RVMD - Revolution Medicines, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 76155X100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RVMD - Revolution Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	3.1%	6,057,931	$154,538,000	—	31 Mar 2022	13F
TRV GP III, LLC	13F	Company	2.9%	5,524,031	$140,918,000	—	31 Mar 2022	13F
Third Rock Ventures III, L.P.	3/4/5	10%+ Owner	— class O/S missing	5,104,130	$137,811,510	—	08 Jun 2022	3/4/5
BlackRock Finance, Inc.	13F	Company	2.8%	5,340,288	$136,230,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.1%	4,083,989	$104,183,000	—	31 Mar 2022	13F
Nextech Invest Ltd.	13F	Company	2%	3,939,529	$100,497,000	—	31 Mar 2022	13F
Boxer Capital, LLC	13F	Company	1.8%	3,484,264	$88,884,000	—	31 Mar 2022	13F
Column Group LLC	13F	Company	1.7%	3,347,245	$85,388,000	—	31 Mar 2022	13F
Bellevue Group AG	13F	Company	1.7%	3,310,662	$84,455,000	—	31 Mar 2022	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.7%	3,250,000	$82,908,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	1.5%	2,867,020	$73,138,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	1.5%	2,843,477	$72,537,000	—	31 Mar 2022	13F
Casdin Capital, LLC	13F	Company	1.2%	2,370,000	$60,459,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	1.2%	2,331,395	$59,474,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.2%	2,299,816	$58,668,000	—	31 Mar 2022	13F
Cormorant Asset Management, LP	13F	Company	1%	1,995,066	$50,894,000	—	31 Mar 2022	13F
BVF INC/IL	13F	Company	0.94%	1,810,549	$46,187,000	—	31 Mar 2022	13F
TRV GP IV, LLC	13F	Company	0.74%	1,419,900	$36,222,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.69%	1,340,615	$34,200,000	—	31 Mar 2022	13F
EcoR1 Capital, LLC	13F	Company	0.66%	1,274,097	$32,502,000	—	31 Mar 2022	13F
Capital World Investors	13F	Company	0.64%	1,228,000	$31,326,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.58%	1,120,941	$28,595,000	—	31 Mar 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.5%	970,514	$24,754,000	—	31 Mar 2022	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.46%	891,587	$22,744,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.45%	869,507	$22,181,000	—	31 Mar 2022	13F
Ponoi II Management, LLC	13F	Company	0.35%	685,011	$17,475,000	—	31 Mar 2022	13F
Ponoi Management, LLC	13F	Company	0.35%	685,011	$17,475,000	—	31 Mar 2022	13F
HARVARD MANAGEMENT CO INC	13F	Company	0.35%	670,382	$17,101,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.33%	629,849	$16,067,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.25%	478,776	$12,214,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.24%	472,551	$12,054,776	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.23%	444,212	$11,332,000	—	31 Mar 2022	13F
BESSEMER GROUP INC	13F	Company	0.23%	438,054	$11,175,000	—	31 Mar 2022	13F
S.c.a. Candriam	13F	Individual	0.23%	434,186	$11,076,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.2%	392,098	$10,002,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.14%	261,808	$6,679,000	—	31 Mar 2022	13F
DAFNA Capital Management LLC	13F	Company	0.12%	232,101	$5,921,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.12%	225,668	$5,757,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	0.12%	222,222	$5,669,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.11%	210,573	$5,371,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.1%	187,769	$4,790,000	—	31 Mar 2022	13F
Tri Locum Partners LP	13F	Company	0.09%	170,455	$4,348,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.11%	208,968	$4,338,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.08%	157,005	$4,006,000	—	31 Mar 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.08%	148,622	$3,791,000	—	31 Mar 2022	13F
MPM BioImpact LLC	13F	Company	0.08%	146,041	$3,726,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.07%	140,881	$3,594,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.07%	130,000	$3,316,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.06%	113,200	$2,888,000	—	31 Mar 2022	13F
J.P. Morgan Private Wealth Advisors LLC	13F	Company	0.05%	99,104	$2,528,000	—	31 Mar 2022	13F

Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q2 2022

As of 30 Jun 2022, Revolution Medicines, Inc. - Common Stock (RVMD) was held by 125 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 76,461,750 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., TRV GP III, LLC, Column Group LLC, EcoR1 Capital, LLC, Nextech Invest AG, BOXER CAPITAL, LLC, Bellevue Group AG, and FARALLON CAPITAL MANAGEMENT LLC. This page lists 125 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

122

Q2 2022 holders

125

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.